• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-4厘米分化型甲状腺癌的肺叶切除术充足性:中国一项大型回顾性研究

Lobectomy sufficiency for 1-4 cm differential thyroid cancer: a large retrospective study in China.

作者信息

Xu Jun, Yao Qixian, Wu Zhongliang, Dou Wenhuan, Liu Yujing

机构信息

Department of Rehabilitation, The People's Hospital of Suzhou New District, Suzhou, 215008, Jiangsu, China.

Department of Surgery, Community Health Service Center of Suzhou Science & Technology Town, Suzhou, 215008, Jiangsu, China.

出版信息

Sci Rep. 2024 Dec 30;14(1):32113. doi: 10.1038/s41598-024-83893-4.

DOI:10.1038/s41598-024-83893-4
PMID:39738739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11686367/
Abstract

This study aimed to determine whether lobectomy is appropriate for the long-term prognosis of 1-4-cm-sized differential thyroid cancer (DTC). This retrospective study included 2,178 patients with 1-4-cm DTC treated via thyroid lobectomy (LT) or total or near-total thyroidectomy (TT) and who were followed up for at least 3 years. The primary endpoint was a structural incomplete response, which was confirmed via imaging with or without a positive histological or cytological examination. Subgroup analysis was performed according to tumor size. LT was performed in 1,535 patients (70.48%), and TT was conducted in the remaining 643 (29.55%) patients. During an average follow-up period of 48.08 months, the recurrence rate was 7.2% in the LT group and 5.3% in the TT group, which was not significantly different (p = 0.108). There were no significant differences in disease-free survival between both groups (hazard ratio, 1.394; 95% confidence interval, 0.9761-1.990; p = 0.089). In the subgroup analysis, the recurrence rates in the LT group were higher than those in the TT group for both the 2-3-cm (13.6% vs. 2.6%, p < 0.01) and 3-4-cm categories (20.6% vs. 4.8%, p < 0.01). For 1-2-cm DTC, surgeons can choose LT or TT owing to their similar recurrence rate, whereas for 2-4-cm DTC, TT is preferred.

摘要

本研究旨在确定肺叶切除术是否适用于直径1 - 4厘米的分化型甲状腺癌(DTC)的长期预后。这项回顾性研究纳入了2178例接受甲状腺叶切除术(LT)或甲状腺全切除术或近全切除术(TT)治疗且随访至少3年的1 - 4厘米DTC患者。主要终点是结构上的不完全缓解,通过影像学检查并结合或不结合阳性组织学或细胞学检查来确认。根据肿瘤大小进行亚组分析。1535例患者(70.48%)接受了LT,其余643例(29.55%)患者接受了TT。在平均48.08个月的随访期内,LT组的复发率为7.2%,TT组为5.3%,差异无统计学意义(p = 0.108)。两组间无病生存率无显著差异(风险比,1.394;95%置信区间,0.9761 - 1.990;p = 0.089)。在亚组分析中,对于2 - 3厘米(13.6%对2.6%,p < 0.01)和3 - 4厘米类别(20.6%对4.8%,p < 0.01),LT组的复发率均高于TT组。对于1 - 2厘米的DTC,由于复发率相似,外科医生可选择LT或TT,而对于2 - 4厘米的DTC,首选TT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/11686367/7f1347dc75ed/41598_2024_83893_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/11686367/7f1347dc75ed/41598_2024_83893_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/11686367/7f1347dc75ed/41598_2024_83893_Fig1_HTML.jpg

相似文献

1
Lobectomy sufficiency for 1-4 cm differential thyroid cancer: a large retrospective study in China.1-4厘米分化型甲状腺癌的肺叶切除术充足性:中国一项大型回顾性研究
Sci Rep. 2024 Dec 30;14(1):32113. doi: 10.1038/s41598-024-83893-4.
2
Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.甲状腺全切除术与甲状腺叶切除术治疗甲状腺微小乳头状癌的长期疗效:倾向评分匹配后对比分析。
Thyroid. 2013 Nov;23(11):1408-15. doi: 10.1089/thy.2012.0463. Epub 2013 Jul 17.
3
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.根据甲状腺切除术的范围,1 至 4 厘米分化型甲状腺癌患者的肿瘤学结果。
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.
4
Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model.低危分化型甲状腺癌患者的全甲状腺切除术或甲状腺叶切除术:使用数学模型对一个争议问题的手术决策分析
World J Surg. 2000 Nov;24(11):1295-302. doi: 10.1007/s002680010215.
5
Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.全甲状腺切除术与叶切除术治疗中危甲状腺乳头状癌:单机构配对分析。
Oral Oncol. 2019 Mar;90:17-22. doi: 10.1016/j.oraloncology.2019.01.010. Epub 2019 Jan 31.
6
The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross-sectional study.甲状腺微小乳头状癌患者行腺叶切除术或甲状腺全切除术的生活质量:一项横断面研究。
Cancer Med. 2021 Mar;10(6):1989-2002. doi: 10.1002/cam4.3747. Epub 2021 Feb 26.
7
Continuing controversy regarding individualized surgical decision-making for patients with 1-4 cm low-risk differentiated thyroid carcinoma: A systematic review.针对 1-4cm 低危分化型甲状腺癌患者的个体化手术决策的持续争议:一项系统综述。
Eur J Surg Oncol. 2020 Dec;46(12):2174-2184. doi: 10.1016/j.ejso.2020.08.014. Epub 2020 Aug 28.
8
A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.在患有甲状腺微小乳头状癌的患者中,行肺叶切除术与甲状腺全切除术的比较:一项回顾性个体风险因素匹配队列研究。
Eur J Endocrinol. 2017 Apr;176(4):371-378. doi: 10.1530/EJE-16-0845. Epub 2017 Jan 15.
9
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence.全甲状腺切除术或甲状腺叶切除术与低至中度复发风险分化型甲状腺癌患者生活质量的关系。
JAMA Surg. 2022 Mar 1;157(3):200-209. doi: 10.1001/jamasurg.2021.6442.
10
Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.全甲状腺切除术与甲状腺叶切除术治疗甲状腺乳头状癌的对比分析:倾向评分匹配后比较分析:一项多中心研究。
Int J Surg. 2017 Feb;38:143-148. doi: 10.1016/j.ijsu.2016.09.083. Epub 2016 Sep 24.

本文引用的文献

1
[Cancer statistics in China, 2016].《2016年中国癌症统计数据》
Zhonghua Zhong Liu Za Zhi. 2023 Mar 23;45(3):212-220. doi: 10.3760/cma.j.cn112152-20220922-00647.
2
Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018.美国甲状腺癌发病率和死亡率趋势:2000-2018 年。
Thyroid. 2022 May;32(5):560-570. doi: 10.1089/thy.2021.0662. Epub 2022 Mar 15.
3
The Year in Surgical Thyroidology: Recent Technological Developments and Future Challenges.《外科甲状腺学年度回顾:近期技术进展与未来挑战》。
Thyroid. 2022 Jan;32(1):14-18. doi: 10.1089/thy.2021.0590. Epub 2022 Jan 5.
4
Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.超声引导下射频消融术与甲状腺叶切除术治疗低危甲状腺微小乳头状癌:884例患者的倾向评分匹配队列研究
Thyroid. 2021 Nov;31(11):1662-1672. doi: 10.1089/thy.2021.0100. Epub 2021 Sep 17.
5
Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up.甲状腺乳头状癌死亡率和复发率的时变模式:长期随访的经验教训。
Thyroid. 2019 Jun;29(6):802-808. doi: 10.1089/thy.2018.0128. Epub 2019 May 1.
6
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.根据甲状腺切除术的范围,1 至 4 厘米分化型甲状腺癌患者的肿瘤学结果。
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.
7
Thyroid cancer "epidemic" also occurs in low- and middle-income countries.甲状腺癌“流行”也发生在中低收入国家。
Int J Cancer. 2019 May 1;144(9):2082-2087. doi: 10.1002/ijc.31884. Epub 2018 Nov 5.
8
The changing incidence of thyroid cancer.甲状腺癌发病率的变化
Nat Rev Endocrinol. 2016 Nov;12(11):646-653. doi: 10.1038/nrendo.2016.110. Epub 2016 Jul 15.
9
Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.对于直径1至4厘米且无临床可识别高危特征的乳头状甲状腺癌,肺叶切除术比全甲状腺切除术更具成本效益。
Ann Surg Oncol. 2016 Oct;23(11):3641-3652. doi: 10.1245/s10434-016-5280-6. Epub 2016 May 24.
10
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.